Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?: https://g.foolcdn.com/editorial/images/778155/businessmen-and-doctors-working-on-touchpad-in-a-hospital.jpg
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?

With some promising clinical trial results in hand and more that could be on the way relatively soon, Amgen's (NASDAQ: AMGN) latest attempt to develop a therapy for obesity is looking like it could

How Much Will Pfizer Pay Out in Dividends This Year?: https://g.foolcdn.com/editorial/images/778246/investor-with-computer-getty.jpg
How Much Will Pfizer Pay Out in Dividends This Year?

A vaccine and an antiviral treatment for COVID-19 made Pfizer (NYSE: PFE) a household name in recent years, but this isn't all the company sells. There are dozens of innovative medicines in its

How Much Will Pfizer Pay Out in Dividends This Year?: https://g.foolcdn.com/editorial/images/778246/investor-with-computer-getty.jpg
How Much Will Pfizer Pay Out in Dividends This Year?

A vaccine and an antiviral treatment for COVID-19 made Pfizer (NYSE: PFE) a household name in recent years, but this isn't all the company sells. There are dozens of innovative medicines in its

Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?: https://g.foolcdn.com/editorial/images/778531/happy-investor-stock-chart-getty.jpg
Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?

Shares of Medtronic (NYSE: MDT) responded poorly to the company's latest quarterly results announcement. The market knocked the stock about 5% lower on May 23, but some analysts who follow the

2 Biotech Stocks to Buy in May: https://g.foolcdn.com/editorial/images/778167/physician-giving-medicine-to-elderly-patient.jpg
2 Biotech Stocks to Buy in May

The stock market has performed relatively well since the beginning of the year although, of course, there is no guarantee that it will maintain that momentum. Who knows what curve ball the future

2 Biotech Stocks to Buy in May: https://g.foolcdn.com/editorial/images/778167/physician-giving-medicine-to-elderly-patient.jpg
2 Biotech Stocks to Buy in May

The stock market has performed relatively well since the beginning of the year although, of course, there is no guarantee that it will maintain that momentum. Who knows what curve ball the future

2 Biotech Stocks to Buy in May: https://g.foolcdn.com/editorial/images/778167/physician-giving-medicine-to-elderly-patient.jpg
2 Biotech Stocks to Buy in May

The stock market has performed relatively well since the beginning of the year although, of course, there is no guarantee that it will maintain that momentum. Who knows what curve ball the future

1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/778007/person-working-at-a-desk.jpg
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever

When looking to invest in dividend stocks, chasing high yields isn't always an advisable strategy. Companies with juicy yields are only worth investing in provided they can support their payouts. We

1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/778007/person-working-at-a-desk.jpg
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever

When looking to invest in dividend stocks, chasing high yields isn't always an advisable strategy. Companies with juicy yields are only worth investing in provided they can support their payouts. We

Where Will Viking Therapeutics Be in 5 Years?: https://g.foolcdn.com/editorial/images/777841/pharmacist-reviewing-checklist.jpg
Where Will Viking Therapeutics Be in 5 Years?

If you're looking at up-and-coming healthcare stocks with significant potential in the anti-obesity market, one company you've likely come across is Viking Therapeutics (NASDAQ: VKTX). Although the

3 High-Flying Stocks That Could Soar Even More: https://g.foolcdn.com/editorial/images/778486/stock-chart-rocket.jpg
3 High-Flying Stocks That Could Soar Even More

What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run.

We asked three Motley Fool contributors to look among

3 High-Flying Stocks That Could Soar Even More: https://g.foolcdn.com/editorial/images/778486/stock-chart-rocket.jpg
3 High-Flying Stocks That Could Soar Even More

What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run.

We asked three Motley Fool contributors to look among

3 High-Flying Stocks That Could Soar Even More: https://g.foolcdn.com/editorial/images/778486/stock-chart-rocket.jpg
3 High-Flying Stocks That Could Soar Even More

What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run.

We asked three Motley Fool contributors to look among

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever: https://g.foolcdn.com/editorial/images/778414/passive-income.jpg
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

Relax, do what you enjoy, and rake in money. That probably sounds like a great life for most people. Making it a reality isn't easy, but it's possible.

The key is to generate passive income. You'll

Is This Hot IPO the Next Carnival?: https://g.foolcdn.com/editorial/images/778529/gettyimages-77146614.jpg
Is This Hot IPO the Next Carnival?

The inviting market waters greeted a new cruise line operator earlier this month. Viking (NYSE: VIK) completed its initial public offering (IPO) on May 1, pricing a little more than 64 million

2 Stocks That Could 10x by 2035: https://g.foolcdn.com/editorial/images/777658/doctor-holding-elderly-patients-hand.jpg
2 Stocks That Could 10x by 2035

Things aren't so bad for investors right now. We are in a bull market even though the economy is still having some problems. However, this bull run won't last forever. There will be a slowdown

Medtronic (MDT) Q4 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Medtronic (MDT) Q4 2024 Earnings Call Transcript

Image source: The Motley Fool.

Medtronic (NYSE: MDT)Q4 2024 Earnings CallMay 23, 2024, 8:00 a.m. ET

Ryan Weispfenning

Continue reading

Source Fool.com

Why Medtronic Stock Slumped Today: https://g.foolcdn.com/editorial/images/778429/1-simple-red-arrow-declining-stock-chart-on-a-white-checked-background.jpg
Why Medtronic Stock Slumped Today

Medtronic (NYSE: MDT) stock slipped 2.8% through 10:15 a.m. ET this morning despite beating earnings forecasts in its fiscal Q4 2024 earnings report.

Heading into earnings, analysts had the medical

3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years: https://g.foolcdn.com/editorial/images/777831/a-couple-sitting-and-using-a-laptop.jpg
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years

The Great Recession ended nearly 15 years ago. Buying stocks toward the end of an economic slowdown can lead to some oversize returns down the road since that usually means you're buying them at

3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years: https://g.foolcdn.com/editorial/images/777831/a-couple-sitting-and-using-a-laptop.jpg
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years

The Great Recession ended nearly 15 years ago. Buying stocks toward the end of an economic slowdown can lead to some oversize returns down the road since that usually means you're buying them at

3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years: https://g.foolcdn.com/editorial/images/777831/a-couple-sitting-and-using-a-laptop.jpg
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years

The Great Recession ended nearly 15 years ago. Buying stocks toward the end of an economic slowdown can lead to some oversize returns down the road since that usually means you're buying them at

EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
Better Buy: Inovio Pharmaceuticals vs. Novavax: https://g.foolcdn.com/editorial/images/777614/person-getting-vaccinated.jpg
Better Buy: Inovio Pharmaceuticals vs. Novavax

The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to dominate this market were much less successful

A Must-Own Stock for Any Portfolio: https://g.foolcdn.com/editorial/images/778200/gettyimages-1720247749.jpg
A Must-Own Stock for Any Portfolio

When it comes to investing, I often look for companies that generate strong amounts of free cash flow (FCF), and companies that can grow their FCF. One company that has proven that over the years is